# Elme Communities: financial statements, quarterly

ELME · NYSE · CIK 104894 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elme.md) · [Financials](/companies/elme/financials.md) · [Filings](/companies/elme/filings.md) · [Insiders](/companies/elme/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/elme/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [55.8](/filings/0000104894-25-000020.md) | [56.6](/filings/0000104894-25-000020.md) | [56.7](/filings/0000104894-25-000020.md) | [58.9](/filings/0000104894-25-000020.md) | [59.5](/filings/0000104894-26-000011.md) | [60.1](/filings/0000104894-26-000011.md) | [61.1](/filings/0000104894-26-000011.md) | [61.3](/filings/0000104894-26-000011.md) | [61.5](/filings/0000104894-26-000019.md) | [62.1](/filings/0000104894-26-000103.md) | [62.1](/filings/0000104894-26-000011.md) | [20.7](/filings/0000104894-26-000011.md) |
| Cost of revenue | $m | [19.5](/filings/0000104894-24-000043.md) | [20.3](/filings/0000104894-24-000077.md) | [19.8](/filings/0000104894-24-000087.md) | [20.3 d](/filings/0000104894-26-000011.md) | [21.7](/filings/0000104894-25-000049.md) | [22.0](/filings/0000104894-25-000087.md) | [22.3](/filings/0000104894-25-000108.md) | [22.7 d](/filings/0000104894-26-000011.md) | [22.0](/filings/0000104894-26-000019.md) | [22.7](/filings/0000104894-26-000103.md) | [24.1](/filings/0000104894-25-000108.md) | not reported |
| Gross profit | $m | [36.3](/filings/0000104894-24-000043.md) | [36.3](/filings/0000104894-24-000077.md) | [36.9](/filings/0000104894-24-000087.md) | [38.6 d](/filings/0000104894-26-000011.md) | [37.8](/filings/0000104894-25-000049.md) | [38.1](/filings/0000104894-25-000087.md) | [38.8](/filings/0000104894-25-000108.md) | [38.5 d](/filings/0000104894-26-000011.md) | [39.5](/filings/0000104894-26-000019.md) | [39.4](/filings/0000104894-26-000103.md) | [38.0](/filings/0000104894-25-000108.md) | not reported |
| Operating income | $m | [3.2](/filings/0000104894-24-000043.md) | [3.6](/filings/0000104894-24-000077.md) | [(36.2)](/filings/0000104894-24-000087.md) | [6.3 d](/filings/0000104894-26-000011.md) | [4.4](/filings/0000104894-25-000049.md) | [5.9](/filings/0000104894-25-000087.md) | [6.7](/filings/0000104894-25-000108.md) | [6.4 d](/filings/0000104894-26-000011.md) | [4.8](/filings/0000104894-26-000019.md) | [5.9](/filings/0000104894-26-000103.md) | [(114)](/filings/0000104894-25-000108.md) | not reported |
| Interest expense | $m | [6.8](/filings/0000104894-24-000043.md) | [6.8](/filings/0000104894-23-000084.md) | [7.4](/filings/0000104894-23-000113.md) | [9.4 d](/filings/0000104894-24-000019.md) | [9.5](/filings/0000104894-24-000043.md) | [9.4](/filings/0000104894-25-000087.md) | [9.6](/filings/0000104894-25-000108.md) | [9.4 d](/filings/0000104894-26-000011.md) | [9.5](/filings/0000104894-26-000019.md) | [9.5](/filings/0000104894-26-000103.md) | [9.7](/filings/0000104894-25-000108.md) | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(3.6)](/filings/0000104894-25-000020.md) | [(2.6)](/filings/0000104894-25-000020.md) | [(43.6)](/filings/0000104894-25-000020.md) | [(3.1)](/filings/0000104894-25-000020.md) | [(3.6)](/filings/0000104894-26-000011.md) | [(3.5)](/filings/0000104894-26-000011.md) | [(3.0)](/filings/0000104894-26-000011.md) | [(3.0)](/filings/0000104894-26-000011.md) | [(4.7)](/filings/0000104894-26-000019.md) | [(3.6)](/filings/0000104894-26-000011.md) | [(124)](/filings/0000104894-26-000011.md) | [(22.4)](/filings/0000104894-26-000011.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0000104894-25-000020.md) | [(0.03)](/filings/0000104894-25-000020.md) | [(0.50)](/filings/0000104894-25-000020.md) | [(0.04)](/filings/0000104894-25-000020.md) | [(0.04)](/filings/0000104894-26-000011.md) | [(0.04)](/filings/0000104894-26-000011.md) | [(0.03)](/filings/0000104894-26-000011.md) | [(0.03)](/filings/0000104894-26-000011.md) | [(0.05)](/filings/0000104894-26-000019.md) | [(0.04)](/filings/0000104894-26-000103.md) | [(1.40)](/filings/0000104894-26-000011.md) | [(0.25)](/filings/0000104894-26-000011.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0000104894-25-000020.md) | [(0.03)](/filings/0000104894-25-000020.md) | [(0.50)](/filings/0000104894-25-000020.md) | [(0.04)](/filings/0000104894-25-000020.md) | [(0.04)](/filings/0000104894-26-000011.md) | [(0.04)](/filings/0000104894-26-000011.md) | [(0.03)](/filings/0000104894-26-000011.md) | [(0.03)](/filings/0000104894-26-000011.md) | [(0.05)](/filings/0000104894-26-000019.md) | [(0.04)](/filings/0000104894-26-000103.md) | [(1.40)](/filings/0000104894-26-000011.md) | [(0.25)](/filings/0000104894-26-000011.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | period not labelled (2025-10-31) | FY2025 (2025-12-31) | period not labelled (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.0](/filings/0000104894-26-000011.md) | [4.2](/filings/0000104894-25-000049.md) | [5.6](/filings/0000104894-25-000087.md) | [4.8](/filings/0000104894-25-000108.md) | [6.1](/filings/0000104894-26-000011.md) | [6.4](/filings/0000104894-26-000019.md) | [4.8](/filings/0000104894-26-000103.md) | [7.1](/filings/0000104894-25-000108.md) | [6.6](/filings/0000104894-26-000011.md) | not reported | not reported | not reported |
| Total assets | $m | [1,900](/filings/0000104894-26-000011.md) | [1,877](/filings/0000104894-25-000049.md) | [1,861](/filings/0000104894-25-000087.md) | [1,853](/filings/0000104894-25-000108.md) | [1,846](/filings/0000104894-26-000011.md) | [1,828](/filings/0000104894-26-000019.md) | [1,810](/filings/0000104894-26-000103.md) | [1,687](/filings/0000104894-25-000108.md) | not reported | [2,114](/filings/0000104894-26-000103.md) | [585](/filings/0000104894-26-000019.md) | [460](/filings/0000104894-26-000103.md) |
| Total liabilities | $m | [746](/filings/0000104894-25-000020.md) | [740](/filings/0000104894-24-000043.md) | [743](/filings/0000104894-24-000077.md) | [754](/filings/0000104894-24-000087.md) | [764](/filings/0000104894-26-000011.md) | [764](/filings/0000104894-25-000049.md) | [764](/filings/0000104894-25-000087.md) | [778](/filings/0000104894-25-000108.md) | not reported | [1,875](/filings/0000104894-26-000103.md) | [381](/filings/0000104894-26-000019.md) | [293](/filings/0000104894-26-000103.md) |
| Shareholders' equity | $m | [1,154](/filings/0000104894-25-000020.md) | [1,136](/filings/0000104894-24-000043.md) | [1,118](/filings/0000104894-24-000077.md) | [1,099](/filings/0000104894-24-000087.md) | [1,082](/filings/0000104894-26-000011.md) | [1,063](/filings/0000104894-25-000049.md) | [1,046](/filings/0000104894-25-000087.md) | [909](/filings/0000104894-25-000108.md) | [887](/filings/0000104894-26-000011.md) | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.8 d](/filings/0000104894-25-000020.md) | [16.3](/filings/0000104894-24-000043.md) | [30.0 d](/filings/0000104894-24-000077.md) | [15.6 d](/filings/0000104894-24-000087.md) | [22.9 d](/filings/0000104894-26-000011.md) | [21.2](/filings/0000104894-25-000049.md) | [28.9 d](/filings/0000104894-25-000087.md) | [20.7 d](/filings/0000104894-25-000108.md) | [24.5 d](/filings/0000104894-26-000011.md) | [16.2](/filings/0000104894-26-000019.md) | [29.8 d](/filings/0000104894-26-000103.md) | [15.9 d](/filings/0000104894-25-000108.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [14.9 d](/filings/0000104894-25-000020.md) | [14.9](/filings/0000104894-24-000043.md) | [15.9 d](/filings/0000104894-24-000077.md) | [17.7 d](/filings/0000104894-24-000087.md) | [15.8 d](/filings/0000104894-26-000011.md) | [15.9](/filings/0000104894-25-000049.md) | [15.9 d](/filings/0000104894-25-000087.md) | [15.9 d](/filings/0000104894-25-000108.md) | [15.9 d](/filings/0000104894-26-000011.md) | [15.9](/filings/0000104894-26-000019.md) | [15.9 d](/filings/0000104894-26-000103.md) | [15.9 d](/filings/0000104894-25-000108.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [87.2](/filings/0000104894-23-000048.md) | [87.4](/filings/0000104894-23-000084.md) | [87.5](/filings/0000104894-23-000113.md) | [87.6](/filings/0000104894-24-000043.md) | [87.7](/filings/0000104894-24-000077.md) | [87.8](/filings/0000104894-24-000087.md) | [87.9](/filings/0000104894-25-000049.md) | [87.9](/filings/0000104894-25-000087.md) | [87.9](/filings/0000104894-25-000108.md) | [88.1](/filings/0000104894-26-000019.md) | [88.1](/filings/0000104894-26-000103.md) | [88.1](/filings/0000104894-25-000108.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 88,857,883 at 2026-07-30, from the cover of the [10-Q filed 2026-07-31](/filings/0000104894-26-000103.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.